J Cloos相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Pathway activity profiling can predict neoadjuvant endocrine therapy response in HR+ HER2- postmenopausal early stage breast cancer

通路活性分析可以预测HR+ HER2-绝经后早期乳腺癌新辅助内分泌治疗的反应

期刊:Breast Cancer Research

影响因子:5.6

doi:10.1186/s13058-026-02245-4

de Gruil, N; de Groot, A F; Wesseling-Rozendaal, Y; Keizer, D; Koekenbier, C S; Vermeer, S; Cohen, D; Heijns, J B; Mandigers, C M P W; van de Wouw, A J; Cloos-van Balen, M; Ropela, J A; Oosterkamp, H M; van Bekkum, M L; Houtsma, D; Biezen, E den; Liefers, G J; Linn, S C; Kroep, J R

发表日期：2026

文献求助收藏

DOSAGE study: protocol for a phase III non-inferiority randomised trial investigating dose-reduced chemotherapy for advanced colorectal cancer in older patients

DOSAGE 研究：一项 III 期非劣效性随机试验方案，旨在研究老年晚期结直肠癌患者剂量降低化疗的疗效

期刊:BMJ Open

影响因子:2.3

doi:10.1136/bmjopen-2024-089882

Baltussen, Joosje C; van den Bos, Frederiek; Slingerland, Marije; Binda, Trishika R R; Liefers, Gerrit-Jan; van den Hout, Wilbert B; Fiocco, Marta; Verschoor, Arjan J; Cloos-van Balen, Marissa; Holterhues, Cynthia; Houtsma, Danny; Jochems, Anouk; Spierings, Leontine E A M M; van Bodegom-Vos, Leti; Mooijaart, Simon P; Gelderblom, Hans; Speetjens, Frank M; de Glas, Nienke A; Portielje, Johanneke E A

发表日期：2024

文献求助收藏

Prospective validation of the prognostic relevance of CD34+CD38- AML stem cell frequency in the HOVON-SAKK132 trial

HOVON-SAKK132试验中CD34+CD38- AML干细胞频率预后相关性的前瞻性验证

影响因子:23.1

doi:10.1182/blood.2022019160

Ngai, Lok Lam; Hanekamp, Diana; Janssen, Fleur; Carbaat-Ham, Jannemieke; Hofland, Maaike A M A; Fayed, Mona M H E; Kelder, Angèle; Oudshoorn-van Marsbergen, Laura; Scholten, Willemijn J; Snel, Alexander N; Bachas, Costa; Tettero, Jesse M; Breems, Dimitri A; Fischer, Thomas; Gjertsen, Bjørn T; Griškevičius, Laimonas; Juliusson, Gunnar; van de Loosdrecht, Arjan A; Maertens, Johan A; Manz, Markus G; Pabst, Thomas; Passweg, Jakob R; Porkka, Kimmo; Valk, Peter J M; Gradowska, Patrycja; Löwenberg, Bob; de Leeuw, David C; Janssen, Jeroen J W M; Ossenkoppele, Gert J; Cloos, Jacqueline

发育与干细胞

细胞生物学

发表日期：2023

文献求助收藏

Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML

流式细胞术检测自体干细胞分离产品中可测量的残留病灶对急性髓系白血病预后的意义

期刊:Hemasphere

影响因子:14.6

doi:10.1097/HS9.0000000000000981

Tettero, Jesse M; Buisman, Yara; Ngai, Lok Lam; Bachas, Costa; Gjertsen, Bjorn T; Kelder, Angèle; van de Loosdrecht, Arjan A; Manz, Markus G; Pabst, Thomas; Scholten, Willemijn; Ossenkoppele, Gert J; Cloos, Jacqueline; de Leeuw, David C

发育与干细胞

细胞生物学

发表日期：2023

文献求助收藏

Measurable residual disease-guided therapy in intermediate-risk acute myeloid leukemia patients is a valuable strategy in reducing allogeneic transplantation without negatively affecting survival

对于中危急性髓系白血病患者，以可测量的残余病灶为指导的治疗是一种有效的策略，可以在不影响生存率的前提下减少异基因移植。

期刊:Haematologica

影响因子:7.9

doi:10.3324/haematol.2022.282639

Tettero, Jesse M; Ngai, Lok Lam; Bachas, Costa; Breems, Dimitri A; Fischer, Thomas; Gjertsen, Bjorn T; Gradowska, Patrycja; Griskevicius, Laimonas; Janssen, Jeroen J W M; Juliusson, Gunnar; Maertens, Johan; Manz, Markus G; Pabst, Thomas; Passweg, Jakob; Porkka, Kimmo; Valk, Peter J M; Löwenberg, Bob; Ossenkoppele, Gert J; Cloos, Jacqueline

发表日期：2023

文献求助收藏

Structural and Thermal Evolution of an Infant Subduction Shear Zone: Insights From Sub-Ophiolite Metamorphic Rocks Recovered From Oman Drilling Project Site BT-1B

俯冲剪切带早期构造和热演化：来自阿曼BT-1B钻探项目现场回收的蛇绿岩下变质岩的启示

doi:10.1029/2021JB021702

Kotowski, Alissa J; Cloos, Mark; Stockli, Daniel F; Bos Orent, Eytan

发表日期：2021

文献求助收藏

MRD Tailored Therapy in AML: What We Have Learned So Far

急性髓系白血病 (AML) 的 MRD 个体化治疗：我们目前所学到的

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2020.603636

Ngai, Lok Lam; Kelder, Angèle; Janssen, Jeroen J W M; Ossenkoppele, Gert J; Cloos, Jacqueline

发表日期：2020

文献求助收藏

In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL

计算机模拟和临床前药物筛选表明，达沙替尼是一种针对T细胞急性淋巴细胞白血病（T-ALL）的靶向治疗药物。

期刊:Blood Cancer Journal

影响因子:11.6

doi:10.1038/bcj.2017.87

Laukkanen, S; Grönroos, T; Pölönen, P; Kuusanmäki, H; Mehtonen, J; Cloos, J; Ossenkoppele, G; Gjertsen, B; Øystein, B; Heckman, C; Heinäniemi, M; Kontro, M; Lohi, O

细胞生物学

免疫/内分泌

发表日期：2017

文献求助收藏

A clinical update on the role of carfilzomib in the treatment of relapsed or refractory multiple myeloma

卡非佐米在复发或难治性多发性骨髓瘤治疗中的作用的临床进展

期刊:Therapeutic Advances in Hematology

影响因子:3.1

doi:10.1177/2040620716667275

Franken, B; van de Donk, N W C J; Cloos, J C; Zweegman, S; Lokhorst, H M

多发性骨髓瘤

发表日期：2016

文献求助收藏

EphB1 Suppression in Acute Myelogenous Leukemia: Regulating the DNA Damage Control System

急性髓性白血病中的 EphB1 抑制：调节 DNA 损伤控制系统

期刊:Molecular Cancer Research

影响因子:4.1

doi:10.1158/1541-7786.MCR-14-0660-T

K R Kampen, F J G Scherpen, G Garcia-Manero, H Yang, G J L Kaspers, J Cloos, C M Zwaan, M M van den Heuvel-Eibrink, S M Kornblau, E S J M De Bont

发表日期：2015

文献求助收藏